Latest News
-

2025: Year in Review
⏱️34 min read | As we usher in 2026, we look back on the landmark clinical trial findings, advancements in research, regulatory disappointments, and thunderous community unity that will define 2025 for the Huntington’s disease community.
-

'Induced' stem cells make exciting advances
Stem cells from HD patients: becoming important tools for researchers – and now correcting the HD mutation in the lab
-

Phosphodiesterase inhibitors: new HD drugs entering trials soon
CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.
-

Interview: CHDI's scientific team
HDBuzz interviews the top scientists from CHDI, the largest funder of Huntington's disease research in the world.
-

Exercise increases cellular recycling
Exercise boosts cellular recycling in mice. Could this be why exercise is also good for HD – or even help develop dru
-

The HDBuzz Prize for young science writers
Announcing the HDBuzz Prize for young science writers!
-

What's the connection between Huntington's Disease and cancer?
HD patients are less likely to get cancer, according to a study from Sweden – what does this mean?
-

Closing the care gap: new guidelines for HD care
Closing the care gap: new guidelines to help every Huntington's disease patient get great care
-

Stem-cell neurons make the right connections
Replacing neurons in mice with stem cells works much better than expected, suggesting that replacement therapy might
-

2012 Therapeutics Conference: a retrospective
HDBuzz looks back at the 2012 Huntington's Disease Therapeutics Conference

